D
Dean E. Carter
Researcher at University of Arizona
Publications - 77
Citations - 3848
Dean E. Carter is an academic researcher from University of Arizona. The author has contributed to research in topics: Arsenic & Arsenite. The author has an hindex of 29, co-authored 77 publications receiving 3682 citations.
Papers
More filters
Journal ArticleDOI
Monomethylarsonous acid (MMAIII) is more toxic than arsenite in Chang human hepatocytes.
TL;DR: Data demonstrate that MMA(III), an intermediate in in organic arsenic methylation, is highly toxic and again raises the question as to whether methylation of inorganic arsenic is a detoxication process.
Journal ArticleDOI
Reactions of arsenic(III) and arsenic(V) species with glutathione
TL;DR: The solution reactions between GSH and arsenate, arsenite, and their methylated metabolites, monomethylarsonic acid (MMA and dimethylarsinic acid (DMA), were characterized using 1H and 13C NMR under a nitrogen atmosphere to result from direct reactions between the two compounds.
Cobalt in hard metals and cobalt sulfate, gallium arsenide, indium phosphide and vanadium pentoxide
Mario Altamirano-Lozano,Detmar Beyersmann,Dean E. Carter,Bruce A. Fowler,Bice Fubini,Janet Kielhorn,Micheline Kirsch-Volders,Jan Kučera,Yukinori Kusaka,G. Lasfargues,Dominique Lison,Inge Mangelsdor,Damien McElvenny,Benoit Nemery,Joseph H. Roycroft,Magnus Svartengren,Ted Junghans,Steve Olin,Roger A. Renne,David G. Longfellow,Kyriakoula Ziegler-Skylakakis,Robert A. Baan,Vincent Cogliano,Fatiha El Ghissassi,Tony Fletcher,Marlin Friesen,Yann Grosse,Nikolai Napalkov,Béatrice Secretan,Kurt Straif,Zhao Qi Wang,Rosamund Williams +31 more
TL;DR: Members Mario Altamirano-Lozano, Unidad de Investigación en Genética y Toxicología Ambiental (UNIGEN), Facultad de Estudios Superiores-Zaragoza, Battalla del 5 de mayo esq.
Journal ArticleDOI
The metabolism of inorganic arsenic oxides, gallium arsenide, and arsine: a toxicochemical review
TL;DR: There is insufficient evidence to equate the different arsenic compounds, and there are several differences in the toxicity of the arsenic compounds that will require substantial research.
Journal ArticleDOI
Pharmacokinetics of acrylamide in Fisher-334 rats
TL;DR: The rapid elimination of parent compound was due mainly to biotransformation since less that 2% of the dose was excreted unchanged in the urine and bile, and the metabolism of acrylamide appears to be mediated through glutathione conjugation in the liver since the major urinary metabolite was N-acetyl-S-(3-amino-3-oxypropyl)cysteine.